These substances, Abacavir Sulfate, Abarelix, and Abiraterone Acetate, each possess distinct chemical architectures leading to their varying pharmacological effects. Abacavir Sulfate, a nucleoside reverse transcriptase inhibitor, is readily identified ALIBENDOL 26750-81-2 via its molecular formula – C14H15N6O4·H2SO4 – and characteristic luminescent properties observed in techniques such as mass spectrometry and infrared assessment. Abarelix, a gonadotropin-releasing hormone (GnRH) receptor antagonist, presents with a complex peptide sequence, typically requiring amino acid sequencing and peptide mapping for total identification. Finally, Abiraterone Acetate, a CYP17 inhibitor utilized in prostate cancer treatment, can be verified through its particular mass and fragmentation patterns acquired through gas chromatography-mass spectrometry (GC-MS) alongside nuclear magnetic resonance (NMR) analytical data, ensuring its correct chemical characterization.
Directory: Abacavir Sulfate Sulfate (CAS 188062-50-2) & Related Compounds
Explore the extensive product detailing Abacavir Sulfate, identified by CAS number 188062-50-2, and a range of associated materials. Our offering includes several qualities to fulfill specific research and production demands. You'll detailed specs including chemical results and available quantities options. Besides, investigate the array of structurally similar compounds that could be beneficial in the ongoing endeavor. Our listing is structured to aid efficient acquiring of pure research reagents.
Drug Reference: Abarelix and Abiraterone Acetate Chemical Abstract Service Codes
For scientists and pharmaceutical professionals requiring precise drug identification, precise Chemical Abstract Service numbers are vital. Specifically, abarelix, a GnRH-releasing hormone agonist used in treating prostate cancer, is assigned the Registry identifier 65572-21-8. Furthermore, abiraterone acetate, a key drug in advanced tumors, carries the Chemical Abstract Service code 389292-17-3. Careful documentation and confirmation of these Chemical Abstract Service numbers are imperative to guarantee proper molecule recognition and subsequent operations. Such numbers are freely obtainable through multiple chemical repositories. Frequently check recognized references for the latest information.
Active Ingredients: Abacavir Sodium , Abarelix, Abiraterone , Chemical Abstracts Service Numbers
The determination of critical pharmaceutical components often relies on definitive chemical identifiers. Notably, this article succinctly examines three important examples: Abacavir Sulfate, a drug reverse polymerase inhibitor; Abarelix, a hormone stimulator; and Abiraterone Acetate, utilized in tumor treatment. Every compound is associated with a unique Registry number, offering a universal method for identifying details and guaranteeing accurate reporting within the research industry. Consult the respective resources for detailed records and connected data.
Chemical Abstracts Service Number Database: Details for Abacavir Sulfate, Abarelix, Abiraterone Acetate
The comprehensive Chemical Abstracts Service (CAS) registry is an critical resource for chemists and manufacturing professionals alike. This article briefly details data pertaining to three key medicinal compounds: Abacavir Sulfate, a medication used to combat HIV; Abarelix, a antagonist utilized in treatment; and Abiraterone Acetate Salt, a potent drug used in the management of metastatic aggressive cancer. Locating the specific CAS code for each substance allows for certain identification and promotes correct literature retrieval. These individual identifiers are vital for compound validation and uniform documentation across the field.
Utilizing API Material Data: Product Recognition with CAS Registry Numbers
Accurate item determination is essential in the substance industry, and Application Programming Interface substance data provides a consistent method. Specifically, Chemical Abstracts Service numbers act as distinct codes for material substances, enabling effortless integration with collections and systems. Such approach furthermore improves data accuracy but also simplifies workflows related to research, procurement, and compliance submission. Additionally, retrieving this information via an Application Programming Interface facilitates automation and minimizes the chance for manual oversight.